A phase II study of sulofenur, a novel sulfonylurea, in recurrent epithelial ovarian cancer

Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

Martin Gore, I Fryatt, E. Wiltshaw et al. · Gynecologic Oncology · 1990 · 391 citations

Relapsed Carcinoma, Initial Treatment, Medicine +8

Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials

G. Blackledge, F. Lawton, C. W. E. Redman et al. · British Journal of Cancer · 1989 · 259 citations · Full text

Medicine, Metronomic Therapy, Pharmacology +10

Ovarian trials at the Royal Marsden

E. Wiltshaw · Cancer Treatment Reviews · 1985 · 110 citations

Gynecological Surgery, Reproductive Health, Gynecology +5

Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.

Charles W. Taylor, David S. Alberts, Marsha A. Ketcham et al. · Journal of Clinical Oncology · 1989 · 45 citations

Chemoprevention Strategy, Pathology, Pharmacotherapy +16

Evaluation of N-(5-indanylsulfonyl)-N?-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcoma

Peter J. Houghton, Janet A. Houghton, Leann Myers et al. · Cancer Chemotherapy and Pharmacology · 1989 · 43 citations

Medicine, Pharmacotherapy, Anti-cancer Agent +4